IzoView offers a dedicated Breast CT platform that provides true 3D imaging of dense breast tissue, delivering up to 100× the spatial resolution of MRI without compression. The system enables fast, comfortable scans designed to detect cancers that conventional tools may miss, and is currently preparing for a pivotal clinical study to validate its performance.
Funding
$375K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Women with dense breast tissue often receive inadequate imaging from conventional mammography, digital breast tomosynthesis, and MRI, leading to missed cancers and delayed diagnosis. The need for a comfortable, high‑resolution, three‑dimensional breast scan that works well in this underserved population remains unmet.
Solution
IzoView offers a dedicated breast CT platform that captures true 3D images of the breast without compression, addressing the limitations of existing modalities. The system uses a 360‑degree x‑ray acquisition and reconstructs up to 500 ultra‑high‑resolution slices in under 10 seconds, providing spatial detail up to 100 times that of MRI. A patent‑pending optical pre‑scan measures each patient’s breast size and composition, enabling personalized radiation dose selection in real time. The resulting volumetric data are processed by proprietary software to generate diagnostic‑grade images and quantitative metrics, improving lesion detection and characterization in dense tissue. IzoView is positioned for clinical adoption as it prepares for a pivotal study to validate performance in this high‑need segment.
Target Audience
Primary customers are breast imaging centers, radiology departments, and oncology clinics that serve women with dense breast tissue and require advanced diagnostic imaging.
Features
- 360° x‑ray rotation delivering true volumetric breast CT without breast compression
- Spatial resolution up to 100× higher than MRI, enabling detection of sub‑millimeter lesions
- Patent‑pending optical pre‑scan that calculates individualized radiation dose for each exam
- Rapid acquisition (≈10 s scan) and automated reconstruction (~30 s) for high patient throughput
- Dedicated software suite that provides 3D visualization, quantitative analysis, and integration with PACS/EHR
- Designed specifically for dense breast tissue, improving visibility of tumors obscured in conventional imaging